How to Get Prometrium in Washington

Why Prometrium Matters for HRT in Washington

Micronized progesterone is the only FDA-approved bioidentical progestogen for endometrial protection during estrogen therapy. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial (N=875) demonstrated that micronized progesterone paired with conjugated equine estrogens protected the endometrium from hyperplasia while producing more favorable lipid profiles than medroxyprogesterone acetate [1]. In that 3-year trial, the rate of endometrial hyperplasia in the micronized progesterone group was 1%, compared with 0% for medroxyprogesterone acetate and 34% for unopposed estrogen.

Washington state has roughly 1.1 million women between ages 45 and 64, many of whom are candidates for menopausal hormone therapy. Access to Prometrium here is straightforward once you understand three things: who can write the prescription, how to fill it, and what your insurance requires. The sections below cover each step.

Who Can Prescribe Prometrium in Washington

Any provider with prescriptive authority in Washington can write a Prometrium prescription. That includes physicians (MDs and DOs), advanced registered nurse practitioners (ARNPs), and physician assistants (PAs). Washington's Nursing Care Quality Assurance Commission grants ARNPs full practice authority, meaning they do not need a collaborating physician to prescribe Schedule IV or unscheduled medications like Prometrium.

PAs in Washington prescribe under a collaborative agreement with a supervising physician, but routine hormone prescriptions fall within standard PA scope. If your primary care provider is unfamiliar with HRT protocols, a referral to an endocrinologist or menopause-certified clinician is a reasonable next step.

The North American Menopause Society (NAMS) maintains a provider directory filtered by state. NAMS-certified menopause practitioners have completed a competency examination covering progesterone prescribing, dosing, and monitoring. "Micronized progesterone remains the preferred progestogen for most women initiating HRT," the 2022 NAMS position statement notes, "given its favorable cardiovascular and breast safety profile relative to synthetic progestins" [2].

Telehealth Options for Prometrium in Washington

Washington legalized permanent telehealth prescribing authority under SB 5423 (2021), which removed the prior requirement for an in-person visit before initiating a prescription. This means a Washington-licensed provider can evaluate you, order labs, and prescribe Prometrium entirely through a video or audio visit.

Several telehealth platforms now serve Washington residents seeking HRT. The key requirements are identical to an in-person visit: the prescriber must hold an active Washington license, document a clinical evaluation, and confirm the indication. There is no separate telehealth registration for the patient.

Turnaround from a telehealth consultation to prescription transmission typically ranges from same-day to 48 hours, depending on whether the provider requires lab results before prescribing. Most telehealth HRT consultations cost between $75 and $250 without insurance. Some platforms bundle lab orders into that fee. Others send a requisition to a local Quest or Labcorp draw site.

For Washington residents in rural counties east of the Cascades, telehealth eliminates the 60-to-90-mile round trips that many face to reach a menopause-trained prescriber. Digital prescriptions route to any pharmacy in the state, including mail-order services that deliver to ZIP codes without a nearby retail pharmacy.

What Labs Are Required Before Starting Prometrium

No single lab panel is universally mandated before starting progesterone. Clinical guidelines, however, recommend baseline assessments to confirm menopausal status and rule out contraindications.

The Endocrine Society's 2015 clinical practice guideline recommends checking follicle-stimulating hormone (FSH) and estradiol levels in women whose menopausal status is uncertain [3]. A serum FSH above 30 mIU/mL with estradiol below 30 pg/mL generally confirms menopause in a woman over 45 with amenorrhea lasting 12 months or longer.

Beyond hormonal confirmation, most prescribers order:

• Complete metabolic panel (CMP) to assess liver function, since Prometrium is hepatically metabolized and the FDA label advises caution in patients with hepatic impairment [4].
• Lipid panel, given that progesterone type affects HDL cholesterol. In the PEPI trial, micronized progesterone preserved 96% of the HDL benefit conferred by estrogen alone, compared with only 68% preservation with medroxyprogesterone [1].
• Thyroid-stimulating hormone (TSH), because hypothyroidism mimics some menopausal symptoms and may alter dosing considerations.
• Transvaginal ultrasound or endometrial biopsy if the patient reports abnormal uterine bleeding before starting therapy.

These labs are available at any Washington draw site. Results are typically ready within 24 to 72 hours. Once reviewed, the prescriber can transmit the Prometrium prescription electronically.

How to Fill a Prometrium Prescription in Washington

Prometrium is stocked at major retail chains (Walgreens, Rite Aid, Costco, Fred Meyer) and independent pharmacies across Washington. Generic micronized progesterone capsules (manufactured by Teva, Sun Pharma, and others) are also widely available and rated AB-equivalent to brand Prometrium by the FDA.

Retail pricing without insurance. A 30-day supply of generic micronized progesterone 200 mg runs approximately $15 to $45 at most Washington pharmacies. Brand-name Prometrium can cost $150 to $300 for the same supply. GoodRx and similar discount cards frequently bring the generic price below $20.

Mail-order pharmacies. Washington permits mail-order dispensing from both in-state and out-of-state pharmacies licensed by the Washington State Department of Health Pharmacy Quality Assurance Commission. Mail-order can reduce costs further, especially for 90-day supplies.

503A compounding pharmacies. Washington licenses 503A compounding pharmacies to prepare micronized progesterone in non-standard dosage forms (creams, troches, suppositories) when a prescriber determines that the commercially available oral capsule does not meet a patient's clinical needs. These pharmacies operate under state Board of Pharmacy oversight and may ship compounded progesterone within Washington. If your provider writes for a compounded formulation, confirm the pharmacy holds a current Washington 503A license before filling.

Washington Medicaid Coverage and Prior Authorization

Washington Apple Health (Medicaid) covers Prometrium and its generic equivalents for the FDA-approved indication of endometrial protection during HRT. Coverage requires prior authorization (PA).

The PA process involves the prescriber submitting documentation to the Health Care Authority (HCA) that confirms:

1. The patient has an intact uterus.
2. The patient is receiving concomitant estrogen therapy.
3. The prescribed progesterone is for endometrial protection.
4. The dose and duration align with FDA-approved labeling [4].

PA decisions in Washington typically take 24 hours for standard requests and 4 hours for expedited requests when the prescriber certifies urgency. Denials can be appealed through the HCA's fair hearing process.

For commercially insured patients, most Washington health plans (Premera, Regence, Molina, Kaiser Permanente) cover generic micronized progesterone on Tier 1 or Tier 2 formularies without prior authorization. Brand Prometrium often sits on Tier 3 or requires step therapy through the generic first.

The American College of Obstetricians and Gynecologists (ACOG) reaffirmed in Practice Bulletin No. 141 that "progesterone therapy is indicated for all women with a uterus who are using systemic estrogen therapy, to reduce the risk of endometrial cancer" [5]. This guideline language strengthens PA approval requests and insurance appeals.

Prometrium Dosing and Administration

The FDA-approved dosing for endometrial protection is 200 mg orally once daily at bedtime for 12 consecutive days per 28-day cycle when used with cyclic estrogen, or 100 mg to 200 mg continuously when paired with daily estrogen [4].

Bedtime dosing is not arbitrary. Micronized progesterone produces measurable sedation through its neuroactive metabolite allopregnanolone, which acts as a positive allosteric modulator at GABA-A receptors. A pharmacokinetic study published in Fertility and Sterility found that peak serum progesterone levels after a 200 mg oral dose occurred at 2 to 4 hours, coinciding with the window of maximal drowsiness [6]. Taking the capsule at bedtime converts this side effect into a mild sleep benefit.

The capsule should be swallowed whole with water. Prometrium contains peanut oil as a suspension medium. Patients with confirmed peanut allergy should use a compounded micronized progesterone formulation that substitutes a different oil base (olive oil or sunflower oil formulations are available through 503A pharmacies).

Transferring a Prometrium Prescription to Washington

If you are relocating to Washington from another state, your existing Prometrium prescription can transfer to a Washington pharmacy. The process works one of two ways.

Pharmacy-to-pharmacy transfer. Your current pharmacist contacts the receiving Washington pharmacy and transfers the remaining refills. Washington law permits this for non-controlled medications. Since Prometrium is not a scheduled substance, the transfer is straightforward and usually completed within one business day.

New prescription from a Washington-licensed provider. If your current prescription has no remaining refills, or if your out-of-state prescriber cannot be reached, a Washington-licensed provider must issue a new prescription. Telehealth makes this efficient. Most HRT-focused telehealth services can review your records and issue a prescription within one to three business days, assuming labs are current.

Bring your most recent lab results (drawn within the past 6 to 12 months) and a list of current medications to your new provider visit. This avoids duplicate lab draws and speeds the prescribing decision.

Safety Considerations and Monitoring

Micronized progesterone carries a class-wide boxed warning shared by all progestogens approved for HRT. The Women's Health Initiative (WHI) found increased breast cancer risk with combined conjugated equine estrogen plus medroxyprogesterone acetate (HR 1.26 to 95% CI 1.00 to 1.59) over a mean follow-up of 5.6 years [7]. Micronized progesterone was not studied in the WHI.

Observational data from the E3N French cohort (N=80,377 postmenopausal women, median follow-up 8.1 years) reported no statistically significant increase in breast cancer risk with estrogen plus micronized progesterone (RR 1.00 to 95% CI 0.83 to 1.22), while estrogen plus synthetic progestins showed elevated risk (RR 1.69 to 95% CI 1.50 to 1.91) [8]. These findings are observational, not randomized, and cannot be considered definitive proof of safety.

Annual follow-up for women on Prometrium should include a clinical breast exam, discussion of mammography per USPSTF guidelines, and reassessment of symptom relief versus ongoing risk. The Endocrine Society recommends re-evaluating the need for HRT at least annually and using the lowest effective dose for the shortest duration consistent with treatment goals [3].

Liver function tests (ALT, AST) should be checked at baseline and repeated if symptoms of hepatic dysfunction develop. Routine repeat testing in asymptomatic women is not required per current guidelines.